As part of the device miniaturization trend happening worldwide, consumer electronics are becoming increasingly streamlined, with conductive inks, flexible batteries, and other technologies making this possible.

Wearable technology has the means to revolutionize health and wellbeing management, with the introduction of streamlined and miniaturized devices in recent years for diabetes management, assistive audio transcription, and general health stats access.

The healthcare landscape is undergoing its most seismic shift in a generation. The catalyst is the explosive rise of GLP-1 receptor agonists like semaglutide and tirzepatide. Originally developed for type 2 diabetes, these medications have transformed into global blockbusters for weight management and metabolic health.